Automated Breast Ultrasound Systems Market Analysis

Automated Breast Ultrasound Systems Market Analysis

Based on the product, the ABUS market size will reach USD 4.5 billion by 2032. Recent advancements in ABUS have led to a reduction in the duration of cancer diagnosis. Modern ABUS systems utilize advanced transducer technology to acquire three-dimensional images of the entire breast. This three-dimensional imaging capability allows for a more comprehensive assessment of the breast tissue, improving visualization and aiding breast ultrasound for detecting and characterizing abnormalities.
 

Regarding end-use, the hospitals segment amassed around 45% of the automated breast ultrasound systems market share in 2022. Commendable rise in breast cancer-related hospitalizations has increased the utilization of ABUS systems in hospitals. Hospital facilities are equipped with advanced diagnostic tools that help detect the disease accurately in less time. Moreover, the high availability of skilled healthcare professionals in these facilities has increased patient footfalls, supplementing segment progression.
 

North America automated breast ultrasound systems market accumulated 20% of the business revenue in 2022. Growing healthcare spending in the region is supporting industry growth. In May 2022, the U.S. Department of Health and Human Services announced the availability of USD 5 million for community health centers to increase access to cancer screenings. Moreover, the growing prevalence of breast cancer has further bolstered the adoption of automated breast ultrasound systems in the region.